Analysis of the reflex response time of the patellar stabilizer muscles in individuals with patellofemoral pain syndrome

OBJETIVO: Avaliar o tempo de resposta reflexa (TRR) dos músculos vasto medial oblíquo (VMO), vasto lateral oblíquo (VLO) e vasto lateral longo (VLL) em indivíduos clinicamente saudáveis e portadores de síndrome da dor patelofemural (SDPF). MÉTODOS: Foram avaliadas 12 mulheres clinicamente saudáveis e 12 mulheres com SDPF. Os registros eletromiográficos foram obtidos por eletrodos ativos simples conectados a um eletromiógrafo, acionados por um sensor externo fixado sobre a porção média do ligamento da patela a partir de sua percussão. A análise do TRR foi realizada por meio da medida do tempo zero ao pico da resposta elétrica dos músculos VMO, VLO e VLL, em segundos, para ambos os grupos. A análise estatística empregada foi o teste de análise de variância (ANOVA, p< 0,05) e teste Tukey post hoc (p< 0,05) para comparação entre os músculos, e o teste t de Student (p< 0,05) para a comparação entre os grupos. RESULTADOS: Ambos os grupos apresentaram um TRR menor para o músculo VMO, quando comparado aos músculos VLO e VLL; entretanto, não se observou diferença significativa entre os músculos VLO e VLL. Na comparação do TRR entre os grupos, não se observou diferença significativa. CONCLUSÕES: De acordo com esses resultados, pode-se sugerir que o TRR das porções do músculo quadríceps não diferencia indivíduos com SDFP dos indivíduos clinicamente saudáveis, sendo que o VMO apresenta um TRR menor em relação ao VLO e VLL para ambos os grupos.OBJECTIVE: To investigate the reflex response time (RRT) of the vastus medialis obliquus (VMO), vastus lateralis obliquus (VLO) and vastus lateralis longus (VLL) muscles in clinically healthy individuals and subjects with patellofemoral pain syndrome (PPS). METHODS: Twelve clinically health women and twelve women with PPS were evaluated. Electromyography (EMG) records were obtained using active electrodes connected to an electromyograph that was activated by an external sensor attached to the medial portion of the patella ligament, by means of percussion. The RRT was analyzed by measuring the time, in seconds, between zero and peak electrical response of the VMO, VLO and VLL muscles, for both groups. The statistical analysis consisted of analysis of variance (ANOVA, p< 0.05) and the Tukey post-hoc test (p< 0.05) to compare the response between muscles, and Student's t test (p< 0.05) to compare the response between groups. RESULTS: Both groups presented lower RRT for the VMO muscle than for the VLO and VLL muscles. However, no significant difference was seen between the VLO and VLL muscles. There was no significant difference in RRT between the groups. CONCLUSIONS: According to these results, it can be suggested that the RRTs in the different portions of the quadriceps muscle do not distinguish between subjects with PPS and clinically healthy individuals. The RRT for the VMO muscle was lower than the RRT for the VLO and VLL muscles, for both groups

Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups

Background: Canagliflozin reduces the risk of kidney failure in patients with type 2 diabetes mellitus and chronic kidney disease, but effects on specific cardiovascular outcomes are uncertain, as are effects in people without previous cardiovascular disease (primary prevention). Methods: In CREDENCE (Canagliflozin and Renal Events in Diabetes With Established Nephropathy Clinical Evaluation), 4401 participants with type 2 diabetes mellitus and chronic kidney disease were randomly assigned to canagliflozin or placebo on a background of optimized standard of care. Results: Primary prevention participants (n=2181, 49.6%) were younger (61 versus 65 years), were more often female (37% versus 31%), and had shorter duration of diabetes mellitus (15 years versus 16 years) compared with secondary prevention participants (n=2220, 50.4%). Canagliflozin reduced the risk of major cardiovascular events overall (hazard ratio [HR], 0.80 [95% CI, 0.67-0.95]; P=0.01), with consistent reductions in both the primary (HR, 0.68 [95% CI, 0.49-0.94]) and secondary (HR, 0.85 [95% CI, 0.69-1.06]) prevention groups (P for interaction=0.25). Effects were also similar for the components of the composite including cardiovascular death (HR, 0.78 [95% CI, 0.61-1.00]), nonfatal myocardial infarction (HR, 0.81 [95% CI, 0.59-1.10]), and nonfatal stroke (HR, 0.80 [95% CI, 0.56-1.15]). The risk of the primary composite renal outcome and the composite of cardiovascular death or hospitalization for heart failure were also consistently reduced in both the primary and secondary prevention groups (P for interaction &gt;0.5 for each outcome). Conclusions: Canagliflozin significantly reduced major cardiovascular events and kidney failure in patients with type 2 diabetes mellitus and chronic kidney disease, including in participants who did not have previous cardiovascular disease

Normal patellofemoral kinematic patterns during daily activities in dogs

Background: Patellar abnormalities are a common cause of pain and lameness in dogs; however, in vivo the relative motion between the femur and patella in dogs is not well described. The objective of this study was to define normal in vivo sagittal plane patellofemoral kinematics in three axes of motion using non-invasive methods. We hypothesized patellofemoral alignment in the sagittal plane would tightly correlate with the femorotibial flexion angle. Six healthy dogs without orthopedic disease underwent computed tomography (CT) of their hind limbs to create 3-D models of the patella and femur. Normal stifle joint motion was captured via flat-panel imaging while each dog performed a series of routine activities, including sitting, walking, and trotting. The 3-D models of the patella and femur were digitally superimposed over the radiographic images with shape-matching software and the precise movement of the patella relative to the femur was calculated. Results: As the femorotibial joint flexed, the patellofemoral joint also flexed and the patella moved caudally and distally within the femoral trochlea during each activity. Patellar flexion and distal translation during walk and sit were linearly coupled with the femorotibial flexion angle. Offset was evident while trotting, where patella poses were significantly different between early and late swing phase (p ≤ 0.003). Patellar flexion ranged from 51 to 6° while trotting. The largest flexion angle (92°) occurred during sit. The patella traversed the entire proximodistal length of the femoral trochlea during these daily activities. Conclusions: Using single-plane flat-panel imaging, we demonstrated normal in vivo patellofemoral kinematics is tightly coupled with femorotibial kinematics; however, trot kinematic patterns did not follow the path defined by walking and stand-to-sit motions. Our normal data can be used in future studies to help define patellofemoral joint kinematics in dogs with stifle abnormalities